E
Efrat Levy
Researcher at Nathan Kline Institute for Psychiatric Research
Publications - 23
Citations - 729
Efrat Levy is an academic researcher from Nathan Kline Institute for Psychiatric Research. The author has contributed to research in topics: Exosome & Cystatin C. The author has an hindex of 12, co-authored 23 publications receiving 462 citations.
Papers
More filters
Journal ArticleDOI
Mitovesicles are a novel population of extracellular vesicles of mitochondrial origin altered in Down syndrome.
Pasquale D’Acunzo,Pasquale D’Acunzo,Rocío Pérez-González,Rocío Pérez-González,Yohan Kim,Yohan Kim,Tal Hargash,Chelsea N. Miller,Melissa J. Alldred,Melissa J. Alldred,Hediye Erdjument-Bromage,Sai C. Penikalapati,Monika Pawlik,Mitsuo Saito,Mitsuo Saito,Mariko Saito,Mariko Saito,Stephen D. Ginsberg,Thomas A. Neubert,Chris N. Goulbourne,Efrat Levy +20 more
TL;DR: Using a high-resolution density gradient separation of extracellular vesicles (EVs) isolated from murine and human DS and diploid control brains, this paper identified and characterized a previously unknown population of double-membraned EVs containing multiple mitochondrial proteins distinct from previously described EV subtypes, including microvesicles and exosomes.
Journal ArticleDOI
Enhanced exosome secretion in Down syndrome brain - a protective mechanism to alleviate neuronal endosomal abnormalities
Sebastien A. Gauthier,Rocío Pérez-González,Ajay Sharma,Fang-Ke Huang,Melissa J. Alldred,Melissa J. Alldred,Monika Pawlik,Gurjinder Kaur,Stephen D. Ginsberg,Thomas A. Neubert,Efrat Levy +10 more
TL;DR: It is found that exosome secretion is enhanced in the brains of DS patients and a mouse model of the disease, and by DS fibroblasts, and increased levels of the tetraspanin CD63, a regulator ofExosome biogenesis, were observed in DS brains, suggesting the upregulation of exosomes represents a potential therapeutic goal for neurodegenerative disorders with endosomal pathology.
Journal ArticleDOI
The Endosomal-Lysosomal Pathway Is Dysregulated by APOE4 Expression in Vivo.
Tal Nuriel,Katherine Y. Peng,Archana Ashok,Allissa Dillman,Helen Y. Figueroa,Justin Apuzzo,Jayanth Ambat,Efrat Levy,Mark R. Cookson,Paul M. Mathews,Paul M. Mathews,Karen Duff +11 more
TL;DR: Findings directly link the APOE4 genotype to endosomal–lysosomal dysregulation in an in vivo, AD pathology-free setting, which may play a causative role in the increased incidence of AD among APoe4 carriers.
Journal ArticleDOI
Apolipoprotein E4 genotype compromises brain exosome production.
Katherine Y. Peng,Katherine Y. Peng,Rocío Pérez-González,Melissa J. Alldred,Melissa J. Alldred,Chris N. Goulbourne,Jose Morales-Corraliza,Jose Morales-Corraliza,Mariko Saito,Mitsuo Saito,Stephen D. Ginsberg,Paul M. Mathews,Paul M. Mathews,Efrat Levy +13 more
TL;DR: Using human and mouse tissue, Peng et al. report that APOE4 reduces brain exosome production and release, which may be the initial event in endosomal-lysosome-exosomal alterations contributing to neuronal vulnerability and neurodegenerative risk in APoe4-carriers.
Journal ArticleDOI
Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model.
Jennifer H.K. Choi,Jason D. Berger,Matthew J. Mazzella,Jose Morales-Corraliza,Anne M. Cataldo,Anne M. Cataldo,Ralph A. Nixon,Ralph A. Nixon,Stephen D. Ginsberg,Efrat Levy,Paul M. Mathews +10 more
TL;DR: Brain levels of both Aβ40 and Aβ42 were not increased in Ts65Dn mice compared with diploid mice at all ages examined, suggesting multiple mechanisms contribute to the regulation towards diploids levels of APP metabolites in the Ts 65Dn mouse brain.